SCHEMBL2909847

SCHEMBL2909847

CS(=O)(=O)N(c1nncs1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
CYP3A5 P20815 3/20 0.36
SLC6A9 P48067 3/20 0.35
FFAR2 O15552 1/20 0.34
ALDH1A1 P00352 1/20 0.32
CYP2D6 P10635 2/20 0.32
CYP19A1 P11511 2/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
BCL2 P10415 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32
TBXA2R P21731 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
ADRA1A P35348 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906595 0.82 FFAR2 (0.42) CYP3A4CYP3A5SLC6A9FFAR2ALDH1A1
SCHEMBL1990049 0.76 MEN1 (0.45) FFAR2ALDH1A1TSHR
SCHEMBL2906510 0.75 MAPT (0.38) CYP3A4CYP3A5SLC6A9ALDH1A1CYP2D6
SCHEMBL2138820 0.74 CYP3A4 (0.55) CYP3A4CYP3A5ALDH1A1CYP19A1
SCHEMBL2138189 0.74 CYP3A4 (0.39) CYP3A4CYP3A5SLC6A9ALDH1A1CYP2D6
Drinabant SCHEMBL684143 0.74 CYP3A4 (0.36) CYP3A4CYP3A5SLC6A9ALDH1A1CYP2D6
SCHEMBL2914551 0.72 CYP3A4 (0.40) CYP3A4CYP3A5SLC6A9CYP2D6CYP19A1
SCHEMBL4711968 0.72 CYP3A4 (0.42) CYP3A4CYP3A5SLC6A9ALDH1A1CHRM2
SCHEMBL2906643 0.71 CACNA2D1 (0.39) CYP3A4CYP3A5SLC6A9CYP2D6CHRM2
SCHEMBL2906645 0.71 SLC6A9 (0.36) CYP3A4CYP3A5SLC6A9ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263722-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND PREPARATION THEREOF AVENTIS PHARMA SA (FR) 2010-08-25 EP disclosed
CN-1418192-A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof AVENTIS PHARMA SA (FR) 2003-05-14 CN disclosed
EP-1263722-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND PREPARATION THEREOF Aventis Pharma S.A. (FR) 2002-12-11 EP disclosed
US-6355631-B1 TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA AVENTIS PHARMA S.A. (FR) 2002-03-12 US disclosed
WO-2001064634-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND PREPARATION THEREOF AVENTIS PHARMA S.A. (FR) 2001-09-07 WO disclosed